Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The company has cut more than 450 jobs since March 2025 in an effort to tighten its budget
The company has already demonstrated the value of its technology in two approved products, namely Yorvipath (palopegteriparatide), a modified version of parathyroid hormone (PTH), which is for the treatment of hypoparathyroidism in adults, and Skytrofa (lonapegsomatropin), a long-acting growth hormone for children with growth hormone deficiency
High concentration samples were omitted because of a bulk shift from buffer mismatch in the preparation of the samples from the stock solution, solubilized in water
Plus, numerous downregulated pathways involving monocytes suggested they were stuck in an immature, naive state
9 Figure 2
US$ 23.61
US$ 25.06
US$ 25.36
